inscreenex GmbH
Engineered Cells for Science and Pharma
Engineered Cells for Science and Pharma
InSCREENeX GmbH is a biotechnology startup that specializes in engineered cells for science and pharma. Founded in 2009, the company utilizes advanced genetic manipulation techniques to engineer mammalian cells, offering SCREENflex™ and CI-SCREEN™ as decision-making tools for drug development processes. The SCREENflex™ technology enables the creation of stable transgenic cell lines 50-70% faster than conventional recombinant techniques, while ensuring unparalleled quality in expression levels and stability. On the other hand, CI-SCREEN™ technology facilitates the creation of physiologically relevant cell systems in sufficient quantity for use in drug development campaigns. InSCREENeX represents an innovative player in the biotech industry, providing valuable solutions for drug developers and researchers.
There is no investment information
No recent news or press coverage available for inscreenex GmbH.
We care about your data, and we'd love to use cookies make your experience better.
